Gilead Sciences, Inc.
FORMULATIONS OF A COMPOUND AND USES THEREOF
Last updated:
Abstract:
The present disclosure relates to formulations, such as tablets, of FXR agonists and therapeutic uses thereof. The disclosure also relates to methods for obtaining such formulations.
Status:
Application
Type:
Utility
Filling date:
9 Mar 2020
Issue date:
8 Oct 2020